Can Nirma make the jump from suds to pills?
Finshots Daily
00:00
Exploring Nirma's Potential Growth Avenues
Exploring Nirma's potential pricing power and recent foray into high value oncology APIs, along with the benefits of Indian government initiatives to reduce import dependence and incentivize domestic pharma. Also discussing the potential value unlocking through the CDMO business model for Nirma.
Play episode from 06:19
Transcript
